Follicular lymphoma, unspecified, unspecified site
ICD-10 C82.90 is a billable code used to indicate a diagnosis of follicular lymphoma, unspecified, unspecified site.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. It is typically indolent, meaning it often progresses slowly, and can present at various stages. The unspecified site indicates that the lymphoma has not been localized to a specific anatomical region, which can complicate treatment and prognosis. Patients may present with B-symptoms, which include fever, night sweats, and weight loss, indicating systemic involvement. Staging is crucial in determining the extent of the disease, with the Ann Arbor staging system commonly used. Treatment protocols may vary based on the stage and symptoms, ranging from watchful waiting in asymptomatic cases to chemotherapy, immunotherapy, or radiation therapy in symptomatic or advanced cases. The prognosis for follicular lymphoma can vary widely, with some patients experiencing long periods of remission, while others may have more aggressive disease requiring intensive treatment.
Detailed clinical notes on symptoms, staging, and treatment plans.
Diagnosis of follicular lymphoma, management of treatment side effects, and follow-up care.
Ensure accurate staging and documentation of B-symptoms for treatment planning.
Histopathological reports confirming diagnosis and subtype.
Biopsy interpretation and classification of lymphoid tissue.
Clear documentation of histological findings to support coding.
Used for patients receiving treatment for follicular lymphoma.
Document the specific chemotherapy regimen and patient response.
Oncology specialists should ensure accurate coding of chemotherapy sessions.
Common symptoms include painless swelling of lymph nodes, fever, night sweats, weight loss, and fatigue. B-symptoms can indicate more advanced disease.
